Iron deficiency anemia among infants: a retrospective cohort study

Vered Shkalim Zemer1,2, Michal Barzel Weinberger1,3, Dafna Nesselroth1,3

  • 1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PubMed

Insights

Postnatal iron deficiency anemia affects over 4% of infants aged 9-18 months in central Israel. Arab and ultraorthodox Jewish infants, along with those of lower socioeconomic status, are at higher risk.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Postnatal iron deficiency (ID) during infancy (6-24 months) has lasting effects into adulthood.
  • Early identification and management of iron deficiency anemia (IDA) are crucial for long-term health outcomes.

Purpose of the Study:

  • To characterize the prevalence and demographic risk factors of IDA in infants aged 9-18 months in a central Israeli district.
  • To identify specific infant subpopulations at increased risk for IDA.

Main Methods:

  • Retrospective chart review of 101,650 infants (aged 9-18 months) from 2010-2021.
  • Analysis of complete blood count (CBC) parameters (hemoglobin, mean corpuscular volume) and demographic data (sex, sector, socioeconomic status, residence).
  • IDA defined as hemoglobin <11 g/dL and mean corpuscular volume <70 fL.

Main Results:

  • Overall IDA prevalence was 4.2% (4296 infants).
  • IDA was significantly more prevalent in Arab (6.6%) and ultraorthodox Jewish (6%) infants compared to non-ultraorthodox Jewish infants (3%).
  • Higher prevalence observed in infants of low socioeconomic status and rural residence.

Conclusions:

  • Arab and ultraorthodox Jewish infants represent high-risk populations for IDA in this region.
  • Enhanced nationwide intervention programs targeting clinicians and parents are recommended to improve IDA detection and treatment.
  • Prompt management of IDA is essential to prevent short- and long-term adverse health consequences.